Recordati ups guidance on strong growth in specialty, primary care markets
Italian drug maker Recordati hiked its 2023 guidance on Thursday, as it posted first-quarter results showing solid growth for its specialty and primary care segments.... | May 11, 2023
Rob Koremans Alvise Armellini Enrico Sciacovelli Executive Rob Koremans Recordati Stock Exchange Press Release
Source: marketscreener.com